Digital Tools Can Help Support Patient Needs, But Human Touch Still Needed
Although there’s a greater trend toward digital communication and monitoring tools, patient trust needs to extend beyond the health care system and their providers.
Major Trends in the 2023 Specialty Therapy Pipeline
The specialty drug pipeline is projected to grow by 8% each year through 2025.
Payers More Likely to Prefer Multiple Biosimilars for the Same Reference Product, Survey Finds
88% of surveyed payers said interchangeability will have the biggest impact on adoption.
Biosimilars Now Look Like a Surer Thing After Initial Skepticism
The Inflation Reduction Act boosted the Medicare payment for biosimilars from the standard average sales price plus 6% to 8%.
Inflation Reduction Act to Allow "Smoothing" of Medicare Part D Out of Pocket Costs
Gottlieb on creating space for opportunity and innovation
At the 2019 Asembia Specialty Pharmacy Summit, former FDA Commissioner Scott Gottlieb discussed advances within the agency during his tenure.
